Preoperative evaluation of patients undergoing lung resection surgery
- PMID: 12796194
- DOI: 10.1378/chest.123.6.2096
Preoperative evaluation of patients undergoing lung resection surgery
Abstract
Lung cancer continues to be the leading case of cancer deaths in the United States. In patients with resectable non-small cell lung cancer, surgical resection is the treatment of choice. An accurate preoperative general and pulmonary-specific evaluation is essential as postoperative complications and morbidity of lung resection surgery are significant. After confirming anatomic resectability, patients must undergo a thorough evaluation to determine their ability to withstand the surgery and the loss of the resected lung. The measurement of spirometric indexes (ie, FEV(1)) and diffusing capacity of the lung for carbon monoxide (DLCO) should be performed first. If FEV(1) and DLCO are > 60% of predicted, patients are at low risk for complications and can undergo pulmonary resection, including pneumonectomy, without further testing. However, if FEV(1) and DLCO are < 60% of predicted, further evaluation by means of a quantitative lung scan is required. If lung scan reveals a predicted postoperative (ppo) values for FEV(1) and DLCO of > 40%, the patient can undergo lung resection. If the ppo FEV(1) and ppo DLCO are < 40%, exercise testing is necessary. If this reveals a maximal oxygen uptake (O(2)max) of > 15 mL/kg, surgery can be undertaken. If the O(2)max is < 15 mL/kg, surgery is not an option. This review discusses the existing modalities for preoperative evaluation prior to lung resection surgery.
Comment in
-
Preoperative pulmonary consultation at a university hospital.Chest. 2004 May;125(5):1966-7; author reply 1967. doi: 10.1378/chest.125.5.1966. Chest. 2004. PMID: 15136422 No abstract available.
Similar articles
-
Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.Chest. 2006 Apr;129(4):863-72. doi: 10.1378/chest.129.4.863. Chest. 2006. PMID: 16608931
-
Preoperative evaluation and risk factors of lung cancer.Rays. 2004 Oct-Dec;29(4):391-400. Rays. 2004. PMID: 15856552 Review.
-
The physiologic evaluation of patients with lung cancer being considered for resectional surgery.Chest. 2003 Jan;123(1 Suppl):105S-114S. doi: 10.1378/chest.123.1_suppl.105s. Chest. 2003. PMID: 12527570
-
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).Chest. 2007 Sep;132(3 Suppl):161S-77S. doi: 10.1378/chest.07-1359. Chest. 2007. PMID: 17873167
-
Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.Gen Thorac Cardiovasc Surg. 2015 Jan;63(1):14-21. doi: 10.1007/s11748-014-0475-x. Epub 2014 Sep 27. Gen Thorac Cardiovasc Surg. 2015. PMID: 25257966 Review.
Cited by
-
Robust imaging approach for precise prediction of postoperative lung function in lung cancer patients prior to curative operation.Thorac Cancer. 2024 Jan;15(1):35-43. doi: 10.1111/1759-7714.15153. Epub 2023 Nov 15. Thorac Cancer. 2024. PMID: 37967873 Free PMC article.
-
Postoperative radiotherapy for non-small cell lung cancer.Cochrane Database Syst Rev. 2016 Sep 29;9(9):CD002142. doi: 10.1002/14651858.CD002142.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2016 Oct 11;10:CD002142. doi: 10.1002/14651858.CD002142.pub4. PMID: 27684386 Free PMC article. Updated. Review.
-
Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer.J Cardiothorac Surg. 2015 Apr 1;10:49. doi: 10.1186/s13019-015-0253-6. J Cardiothorac Surg. 2015. PMID: 25888465 Free PMC article.
-
Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection.J Thorac Dis. 2022 Feb;14(2):536-545. doi: 10.21037/jtd-22-118. J Thorac Dis. 2022. PMID: 35280487 Free PMC article.
-
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.Lancet. 2010 Apr 10;375(9722):1267-77. doi: 10.1016/S0140-6736(10)60059-1. Epub 2010 Mar 24. Lancet. 2010. PMID: 20338627 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical